Click for best price
Psoriasis Drugs Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for Psoriasis Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Psoriasis Drugs. This report contains market size and forecasts of Psoriasis Drugs in global, including the following market information:
Global Psoriasis Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Psoriasis Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Psoriasis is a genetic condition that may not be present at birth. The condition may be triggered by certain environmental and genetic factors. Changing lifestyles of people are leading to increased alcohol consumption and smoking, unhealthy diet, and sedentary living, which makes people more prone to this condition.
We surveyed the Psoriasis Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Psoriasis Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Psoriasis Drugs Market Segment Percentages, by Type, 2022 (%)
Tumor Necrosis Factor Inhibitor
Interleukin Inhibitors
Others
Global Psoriasis Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Psoriasis Drugs Market Segment Percentages, by Application, 2022 (%)
Topicals
Systemic
Biologics
Global Psoriasis Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Psoriasis Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Psoriasis Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Psoriasis Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie
Amgen
Johnson & Johnson
Novartis
Eli Lilly & Company
AstraZeneca
Celgene Corporation
UCB
Merck
Outline of Major Chapters:
Chapter 1: Introduces the definition of Psoriasis Drugs, market overview.
Chapter 2: Global Psoriasis Drugs market size in revenue.
Chapter 3: Detailed analysis of Psoriasis Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Psoriasis Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Psoriasis Drugs Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
69 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Psoriasis Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Psoriasis Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Psoriasis Drugs Overall Market Size
2.1 Global Psoriasis Drugs Market Size: 2022 VS 2029
2.2 Global Psoriasis Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Psoriasis Drugs Players in Global Market
3.2 Top Global Psoriasis Drugs Companies Ranked by Revenue
3.3 Global Psoriasis Drugs Revenue by Companies
3.4 Top 3 and Top 5 Psoriasis Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Psoriasis Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Psoriasis Drugs Players in Global Market
3.6.1 List of Global Tier 1 Psoriasis Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Psoriasis Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Psoriasis Drugs Market Size Markets, 2022 & 2029
4.1.2 Tumor Necrosis Factor Inhibitor
4.1.3 Interleukin Inhibitors
4.1.4 Others
4.2 By Type - Global Psoriasis Drugs Revenue & Forecasts
4.2.1 By Type - Global Psoriasis Drugs Revenue, 2018-2023
4.2.2 By Type - Global Psoriasis Drugs Revenue, 2024-2029
4.2.3 By Type - Global Psoriasis Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Psoriasis Drugs Market Size, 2022 & 2029
5.1.2 Topicals
5.1.3 Systemic
5.1.4 Biologics
5.2 By Application - Global Psoriasis Drugs Revenue & Forecasts
5.2.1 By Application - Global Psoriasis Drugs Revenue, 2018-2023
5.2.2 By Application - Global Psoriasis Drugs Revenue, 2024-2029
5.2.3 By Application - Global Psoriasis Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Psoriasis Drugs Market Size, 2022 & 2029
6.2 By Region - Global Psoriasis Drugs Revenue & Forecasts
6.2.1 By Region - Global Psoriasis Drugs Revenue, 2018-2023
6.2.2 By Region - Global Psoriasis Drugs Revenue, 2024-2029
6.2.3 By Region - Global Psoriasis Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Psoriasis Drugs Revenue, 2018-2029
6.3.2 US Psoriasis Drugs Market Size, 2018-2029
6.3.3 Canada Psoriasis Drugs Market Size, 2018-2029
6.3.4 Mexico Psoriasis Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Psoriasis Drugs Revenue, 2018-2029
6.4.2 Germany Psoriasis Drugs Market Size, 2018-2029
6.4.3 France Psoriasis Drugs Market Size, 2018-2029
6.4.4 U.K. Psoriasis Drugs Market Size, 2018-2029
6.4.5 Italy Psoriasis Drugs Market Size, 2018-2029
6.4.6 Russia Psoriasis Drugs Market Size, 2018-2029
6.4.7 Nordic Countries Psoriasis Drugs Market Size, 2018-2029
6.4.8 Benelux Psoriasis Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Psoriasis Drugs Revenue, 2018-2029
6.5.2 China Psoriasis Drugs Market Size, 2018-2029
6.5.3 Japan Psoriasis Drugs Market Size, 2018-2029
6.5.4 South Korea Psoriasis Drugs Market Size, 2018-2029
6.5.5 Southeast Asia Psoriasis Drugs Market Size, 2018-2029
6.5.6 India Psoriasis Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Psoriasis Drugs Revenue, 2018-2029
6.6.2 Brazil Psoriasis Drugs Market Size, 2018-2029
6.6.3 Argentina Psoriasis Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Psoriasis Drugs Revenue, 2018-2029
6.7.2 Turkey Psoriasis Drugs Market Size, 2018-2029
6.7.3 Israel Psoriasis Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia Psoriasis Drugs Market Size, 2018-2029
6.7.5 UAE Psoriasis Drugs Market Size, 2018-2029
7 Psoriasis Drugs Companies Profiles
7.1 AbbVie
7.1.1 AbbVie Company Summary
7.1.2 AbbVie Business Overview
7.1.3 AbbVie Psoriasis Drugs Major Product Offerings
7.1.4 AbbVie Psoriasis Drugs Revenue in Global Market (2018-2023)
7.1.5 AbbVie Key News & Latest Developments
7.2 Amgen
7.2.1 Amgen Company Summary
7.2.2 Amgen Business Overview
7.2.3 Amgen Psoriasis Drugs Major Product Offerings
7.2.4 Amgen Psoriasis Drugs Revenue in Global Market (2018-2023)
7.2.5 Amgen Key News & Latest Developments
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Company Summary
7.3.2 Johnson & Johnson Business Overview
7.3.3 Johnson & Johnson Psoriasis Drugs Major Product Offerings
7.3.4 Johnson & Johnson Psoriasis Drugs Revenue in Global Market (2018-2023)
7.3.5 Johnson & Johnson Key News & Latest Developments
7.4 Novartis
7.4.1 Novartis Company Summary
7.4.2 Novartis Business Overview
7.4.3 Novartis Psoriasis Drugs Major Product Offerings
7.4.4 Novartis Psoriasis Drugs Revenue in Global Market (2018-2023)
7.4.5 Novartis Key News & Latest Developments
7.5 Eli Lilly & Company
7.5.1 Eli Lilly & Company Company Summary
7.5.2 Eli Lilly & Company Business Overview
7.5.3 Eli Lilly & Company Psoriasis Drugs Major Product Offerings
7.5.4 Eli Lilly & Company Psoriasis Drugs Revenue in Global Market (2018-2023)
7.5.5 Eli Lilly & Company Key News & Latest Developments
7.6 AstraZeneca
7.6.1 AstraZeneca Company Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Psoriasis Drugs Major Product Offerings
7.6.4 AstraZeneca Psoriasis Drugs Revenue in Global Market (2018-2023)
7.6.5 AstraZeneca Key News & Latest Developments
7.7 Celgene Corporation
7.7.1 Celgene Corporation Company Summary
7.7.2 Celgene Corporation Business Overview
7.7.3 Celgene Corporation Psoriasis Drugs Major Product Offerings
7.7.4 Celgene Corporation Psoriasis Drugs Revenue in Global Market (2018-2023)
7.7.5 Celgene Corporation Key News & Latest Developments
7.8 UCB
7.8.1 UCB Company Summary
7.8.2 UCB Business Overview
7.8.3 UCB Psoriasis Drugs Major Product Offerings
7.8.4 UCB Psoriasis Drugs Revenue in Global Market (2018-2023)
7.8.5 UCB Key News & Latest Developments
7.9 Merck
7.9.1 Merck Company Summary
7.9.2 Merck Business Overview
7.9.3 Merck Psoriasis Drugs Major Product Offerings
7.9.4 Merck Psoriasis Drugs Revenue in Global Market (2018-2023)
7.9.5 Merck Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Psoriasis Drugs Market Opportunities & Trends in Global Market
Table 2. Psoriasis Drugs Market Drivers in Global Market
Table 3. Psoriasis Drugs Market Restraints in Global Market
Table 4. Key Players of Psoriasis Drugs in Global Market
Table 5. Top Psoriasis Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Psoriasis Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Psoriasis Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Psoriasis Drugs Product Type
Table 9. List of Global Tier 1 Psoriasis Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Psoriasis Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Psoriasis Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Psoriasis Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Psoriasis Drugs Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Psoriasis Drugs Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Psoriasis Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Psoriasis Drugs Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Psoriasis Drugs Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Psoriasis Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Psoriasis Drugs Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Psoriasis Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Psoriasis Drugs Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Psoriasis Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Psoriasis Drugs Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Psoriasis Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Psoriasis Drugs Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Psoriasis Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Psoriasis Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Psoriasis Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Psoriasis Drugs Revenue, (US$, Mn), 2024-2029
Table 30. AbbVie Company Summary
Table 31. AbbVie Psoriasis Drugs Product Offerings
Table 32. AbbVie Psoriasis Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. AbbVie Key News & Latest Developments
Table 34. Amgen Company Summary
Table 35. Amgen Psoriasis Drugs Product Offerings
Table 36. Amgen Psoriasis Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Amgen Key News & Latest Developments
Table 38. Johnson & Johnson Company Summary
Table 39. Johnson & Johnson Psoriasis Drugs Product Offerings
Table 40. Johnson & Johnson Psoriasis Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Johnson & Johnson Key News & Latest Developments
Table 42. Novartis Company Summary
Table 43. Novartis Psoriasis Drugs Product Offerings
Table 44. Novartis Psoriasis Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Novartis Key News & Latest Developments
Table 46. Eli Lilly & Company Company Summary
Table 47. Eli Lilly & Company Psoriasis Drugs Product Offerings
Table 48. Eli Lilly & Company Psoriasis Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Eli Lilly & Company Key News & Latest Developments
Table 50. AstraZeneca Company Summary
Table 51. AstraZeneca Psoriasis Drugs Product Offerings
Table 52. AstraZeneca Psoriasis Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. AstraZeneca Key News & Latest Developments
Table 54. Celgene Corporation Company Summary
Table 55. Celgene Corporation Psoriasis Drugs Product Offerings
Table 56. Celgene Corporation Psoriasis Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Celgene Corporation Key News & Latest Developments
Table 58. UCB Company Summary
Table 59. UCB Psoriasis Drugs Product Offerings
Table 60. UCB Psoriasis Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. UCB Key News & Latest Developments
Table 62. Merck Company Summary
Table 63. Merck Psoriasis Drugs Product Offerings
Table 64. Merck Psoriasis Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Merck Key News & Latest Developments
List of Figures
Figure 1. Psoriasis Drugs Segment by Type in 2022
Figure 2. Psoriasis Drugs Segment by Application in 2022
Figure 3. Global Psoriasis Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Psoriasis Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Psoriasis Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Psoriasis Drugs Revenue in 2022
Figure 8. By Type - Global Psoriasis Drugs Revenue Market Share, 2018-2029
Figure 9. By Application - Global Psoriasis Drugs Revenue Market Share, 2018-2029
Figure 10. By Type - Global Psoriasis Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Psoriasis Drugs Revenue Market Share, 2018-2029
Figure 12. By Application - Global Psoriasis Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Psoriasis Drugs Revenue Market Share, 2018-2029
Figure 14. By Region - Global Psoriasis Drugs Revenue Market Share, 2018-2029
Figure 15. By Country - North America Psoriasis Drugs Revenue Market Share, 2018-2029
Figure 16. US Psoriasis Drugs Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Psoriasis Drugs Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Psoriasis Drugs Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Psoriasis Drugs Revenue Market Share, 2018-2029
Figure 20. Germany Psoriasis Drugs Revenue, (US$, Mn), 2018-2029
Figure 21. France Psoriasis Drugs Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Psoriasis Drugs Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Psoriasis Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Psoriasis Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Psoriasis Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Psoriasis Drugs Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Psoriasis Drugs Revenue Market Share, 2018-2029
Figure 28. China Psoriasis Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Psoriasis Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Psoriasis Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Psoriasis Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. India Psoriasis Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Psoriasis Drugs Revenue Market Share, 2018-2029
Figure 34. Brazil Psoriasis Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Psoriasis Drugs Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Psoriasis Drugs Revenue Market Share, 2018-2029
Figure 37. Turkey Psoriasis Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Psoriasis Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Psoriasis Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Psoriasis Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. AbbVie Psoriasis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Amgen Psoriasis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Johnson & Johnson Psoriasis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Novartis Psoriasis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Eli Lilly & Company Psoriasis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. AstraZeneca Psoriasis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Celgene Corporation Psoriasis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. UCB Psoriasis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Merck Psoriasis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
